Neuroepidemiology 2007 Sep 11
Plasma titers of antibodies against Epstein-Barr virus BZLF1 and risk of multiple sclerosis.
ABSTRACT
BACKGROUND/AIMS
Results of recently conducted prospective studies have demonstrated that the presence of high titers of anti-EBNA-1 or anti-EBNA complex IgG antibodies in healthy individuals is a strong risk factor for multiple sclerosis (MS). Antibodies to BZLF1, the product of the homonymous early lytic gene, have been found to be related to risk of nasopharyngeal carcinoma, but have not been previously measured in MS studies.
METHODS
We examined whether high levels of anti-BZLF1 IgG antibodies also predict MS risk in a nested case-control study among women in the Nurses Health Study and Nurses Health Study II cohorts.
RESULTS
Results of this prospective study suggest that antibody titers to EBNAs are the strongest predictor of MS risk.
CONCLUSION
Little further contribution may be provided by measuring anti-BZLF1 antibodies in regard to MS risk.
Related Questions
Based on the results of the recent longitudinal analysis linking EBV infection and MS (Bjornevik et al., PMID 35025605), can negative EBV antibodies (...
New answer by at UTHealth (February 2, 2022)
Generally, we do not check for antibodies against either viral capsid antigen (VCA) or Epstein Barr nuclear antigen (EBNA) for our patients with MS or when MS.EBV is considere...